Development and validation of a LC-MS/MS method for assessment of an anti-inflammatory indolinone derivative by in vitro blood-brain barrier models

被引:8
作者
Jaehne, Evelyn A. [1 ]
Eigenmann, Daniela E. [1 ]
Culot, Maxime [2 ]
Cecchelli, Romeo [2 ]
Walter, Fruzsina R. [3 ]
Deli, Maria A. [3 ]
Tremmel, Robin [4 ]
Fricker, Gert [4 ]
Smiesko, Martin [5 ]
Hamburger, Matthias [1 ]
Oufir, Mouhssin [1 ]
机构
[1] Univ Basel, Dept Pharmaceut Sci, Inst Pharmaceut Biol, CH-4056 Basel, Switzerland
[2] Univ Lille Nord France, UArtois, BBB Lab EA 2465, IMPRT IFR114, F-62307 Lens, France
[3] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6726 Szeged, Hungary
[4] Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[5] Univ Basel, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
Isatis tinctoria; (E,Z)-3-(4-Hydroxy-3,5-dimethoxybenzylidene)indolin-2-one; Anti-inflammatory; LC-MS/MS; Blood-brain barrier (BBB); TINCTORIA LEAF EXTRACTS; P-GLYCOPROTEIN EFFLUX; ISATIS-TINCTORIA; ENDOTHELIAL-CELLS; INHIBITORY-ACTIVITY; KINASE INHIBITORS; PURE TRYPTANTHRIN; DRUG DISCOVERY; PERMEABILITY; SYSTEM;
D O I
10.1016/j.jpba.2014.05.026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The compound (E,Z)-3-(4-hydroxy-3,5-dimethoxybenzylidene)indolin-2-one (indolinone) was identified from lipophilic woad extracts (Isatis tinctoria L, Brassicaceae) as a compound possessing potent histamine release inhibitory and anti-inflammatory properties [1]. To further evaluate the potential of indolinone in terms of crossing the blood-brain barrier (BBB), we screened the compound in several in vitro cell-based human and animal BBB models. Therefore, we developed a quantitative LC-MS/MS method for the compound in modified Ringer HEPES buffer (RHB) and validated it according to FDA and EMA guidelines [2,3]. The calibration curve of indolinone in the range between 30.0 and 3000 ng/ml was quadratic, and the limit of quantification was 30.0 ng/ml. Dilution of samples up to 100-fold did not affect precision and accuracy. The carry-over was within acceptance criteria. Indolinone proved to be stable in RHB for 3 h at room temperature (RT), and for three successive freeze/thaw cycles. The processed samples could be stored in the autosampler at 10 degrees C for at least 28 h. Moreover, indolinone was stable for at least 16 days in RHB when stored below -65 degrees C. This validation study demonstrates that our method is specific, selective, precise, accurate, and capable to produce reliable results. In the immortalized human BBB mono-culture model, the apparent permeability coefficient from apical to basolateral (P-app A -> B), and the P-app from basolateral to apical (P-app (B -> A)) were 19.2 +/- 0.485 x 10(-6) cm/s and 21.7 +/- 0.326 x 10-6 cm/s, respectively. For the primary rat/bovine BBB co-culture model a P-app (A -> B) Of 27.1 +/- 1.67 x 10(-6) cm/s was determined. In the primary rat BBB triple co-culture model, the P-app A -> B and the P-app (B -> A) were 56.2 +/- 3.63 x 10(-6) cm/s and 34.6 +/- 1.41 x 10(-6) cm/s, respectively. The data obtained with the different models showed good correlation and were indicative of a high BBB permeation potential of indolinone confirmed by in silica prediction calculations. P-glycoprotein (P-gp) interaction for indolinone was studied with the aid of a calcein-AM uptake assay, and by calculation of the efflux ratio (ER) from the bidirectional permeability assays. For both bidirectional BBB models an ER below 2 was calculated, indicating that no active mediated transport mechanism is involved for indolinone. In porcine brain capillary endothelial cells (PBCECs), the calcein-AM uptake assay demonstrated that indolinone is neither a P-gp substrate nor a P-gp inhibitor and is accumulated into cells at high extent. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 246
页数:12
相关论文
共 51 条
  • [1] [Anonymous], 2011, Science Medicines Health, Guideline on bioanalytical method validation.
  • [2] Compound profiling for p-glycoprotein at the blood-brain barrier using a microplate screening system
    Bauer, B
    Miller, DS
    Fricker, G
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (08) : 1170 - 1176
  • [3] BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97
  • [4] Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: Comparison between primary glial cells and C6 cell line
    Boveri, M
    Berezowski, V
    Price, A
    Slupek, S
    Lenfant, AM
    Benaud, C
    Hartung, T
    Cecchelli, R
    Prieto, P
    Dehouck, MP
    [J]. GLIA, 2005, 51 (03) : 187 - 198
  • [5] In vitro model for evaluating drug transport across the blood-brain barrier
    Cecchelli, R
    Dehouck, B
    Descamps, L
    Fenart, L
    Buée-Scherrer, V
    Duhem, C
    Lundquist, S
    Rentfel, M
    Torpier, G
    Dehouck, MP
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 165 - 178
  • [6] Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis
    Danz, H
    Stoyanova, S
    Thomet, OAR
    Simon, HU
    Dannhardt, G
    Ulbrich, H
    Hamburger, M
    [J]. PLANTA MEDICA, 2002, 68 (10) : 875 - 880
  • [7] Quantitative determination of the dual COX-2/5-LOX inhibitor tryptanthrin in Isatis tinctoria by ESI-LC-MS
    Danz, H
    Baumann, D
    Hamburger, M
    [J]. PLANTA MEDICA, 2002, 68 (02) : 152 - 157
  • [8] Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria
    Danz, H
    Stoyanova, S
    Wippich, P
    Brattström, A
    Hamburger, M
    [J]. PLANTA MEDICA, 2001, 67 (05) : 411 - 416
  • [9] AN EASIER, REPRODUCIBLE, AND MASS-PRODUCTION METHOD TO STUDY THE BLOOD-BRAIN-BARRIER INVITRO
    DEHOUCK, MP
    MERESSE, S
    DELORME, P
    FRUCHART, JC
    CECCHELLI, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (05) : 1798 - 1801
  • [10] Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology
    Deli, MA
    Abraham, CS
    Kataoka, Y
    Niwa, M
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) : 59 - 127